Literature DB >> 11410588

Fibroblast quiescence in floating or released collagen matrices: contribution of the ERK signaling pathway and actin cytoskeletal organization.

J Fringer1, F Grinnell.   

Abstract

Fibroblasts in attached collagen matrices proliferate, whereas cells in floating or released matrices become quiescent. Cells in attached matrices had prominent actin stress fibers, indicating that they were under isometric tension, whereas stress fibers were absent from fibroblasts in floating or released matrices. Compared with cells in attached matrices, cells in floating or released matrices showed down-regulation of cyclin D1 and up-regulation of p27(Kip1) cyclin-dependent kinase inhibitor, and similar changes occurred after the ERK signaling pathway was blocked by UO126 in cells in attached matrices. A different pattern of changes in cell cycle regulatory proteins occurred, however, after serum deprivation or actin cytoskeletal depolymerization by latrunculin B, which did not prevent signaling through the ERK pathway. Therefore, cell quiescence in floating or released collagen matrices could be explained by decreased signaling through the ERK pathway, but these changes were not accounted for by the absence of isometric tension in the cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11410588     DOI: 10.1074/jbc.M101898200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

1.  Serotonin mechanisms in heart valve disease II: the 5-HT2 receptor and its signaling pathway in aortic valve interstitial cells.

Authors:  Jie Xu; Bo Jian; Richard Chu; Zhibin Lu; Quanyi Li; John Dunlop; Sharon Rosenzweig-Lipson; Paul McGonigle; Robert J Levy; Bruce Liang
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

Review 2.  Microenvironmental control of the breast cancer cell cycle.

Authors:  Xun Guo; Yuehan Wu; Helen J Hathaway; Rebecca S Hartley
Journal:  Anat Rec (Hoboken)       Date:  2012-01-24       Impact factor: 2.064

Review 3.  Mammary gland ECM remodeling, stiffness, and mechanosignaling in normal development and tumor progression.

Authors:  Pepper Schedin; Patricia J Keely
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-01-01       Impact factor: 10.005

Review 4.  Cellular and multicellular form and function.

Authors:  Wendy F Liu; Christopher S Chen
Journal:  Adv Drug Deliv Rev       Date:  2007-08-16       Impact factor: 15.470

Review 5.  Fibroblasts in three dimensional matrices: cell migration and matrix remodeling.

Authors:  Sangmyung Rhee
Journal:  Exp Mol Med       Date:  2009-12-31       Impact factor: 8.718

6.  Mechanical signaling through the cytoskeleton regulates cell proliferation by coordinated focal adhesion and Rho GTPase signaling.

Authors:  Paolo P Provenzano; Patricia J Keely
Journal:  J Cell Sci       Date:  2011-04-15       Impact factor: 5.285

7.  Mouse pancreatic islets are resistant to indoleamine 2,3 dioxygenase-induced general control nonderepressible-2 kinase stress pathway and maintain normal viability and function.

Authors:  Reza B Jalili; Farshad Forouzandeh; Alireza Moeenrezakhanlou; Gina R Rayat; Ray V Rajotte; Hasan Uludag; Aziz Ghahary
Journal:  Am J Pathol       Date:  2008-12-12       Impact factor: 4.307

8.  Interaction of serum response factor (SRF) with the Elk-1 B box inhibits RhoA-actin signaling to SRF and potentiates transcriptional activation by Elk-1.

Authors:  Kasumi Murai; Richard Treisman
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

9.  2D and 3D collagen and fibrin biopolymers promote specific ECM and integrin gene expression by vascular smooth muscle cells.

Authors:  Helen Hong; Jan P Stegemann
Journal:  J Biomater Sci Polym Ed       Date:  2008       Impact factor: 3.517

10.  Dimensionality controls cytoskeleton assembly and metabolism of fibroblast cells in response to rigidity and shape.

Authors:  Mirjam Ochsner; Marcus Textor; Viola Vogel; Michael L Smith
Journal:  PLoS One       Date:  2010-03-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.